Skip to main content
Access Resources

MJFF Publications

601 - 610 of 7540 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • RESTRICTED
    Title: A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation
    Journal Name: Drugs
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s40265-023-01838-z
    Citation Count: 9
  • RESTRICTED
    Title: Development of a Novel Electrochemiluminescence ELISA for Quantification of α-Synuclein Phosphorylated at Ser129 in Biological Samples
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00676
    Citation Count: 11
  • RESTRICTED
    Title: Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay
    Journal Name: Journal of Parkinson's Disease
    Publisher: IOS Press
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3233/jpd-213085
    Citation Count: 3
  • RESTRICTED
    Title: Expert Consensus on the Use of On‐Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi Panel
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13690
    Citation Count: 1
  • RESTRICTED
    Title: Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00476-2
    Citation Count: 4
  • RESTRICTED
    Title: Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11C]UCB‐J and [18F]FDG PET Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29375
    Citation Count: 6
  • RESTRICTED
    Title: The Impact of the COVID‐19 Pandemic on Care Partners of People with Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13678
    Citation Count: 0
  • RESTRICTED
    Title: Perceived Discrimination in Health Care for LGBTQIA+ People Living With Parkinson’s Disease
    Journal Name: The Journals of Gerontology: Series B
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1093/geronb/gbad046
    Best OA location URL:
    Citation Count: 1
  • RESTRICTED
    Title: Age and sex differentially shape brain networks in Parkinson's disease
    Journal Name: CNS Neuroscience & Therapeutics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/cns.14149
    Citation Count: 13
  • RESTRICTED
    Title: Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awad072
    Best OA location URL:
    Citation Count: 23
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.